The impact of S2 mutations on Omicron SARS-CoV-2 cell surface expression and fusogenicity.

Omicron SARS-CoV-2 Spike Spike cell surface expression cell-cell fusion ‘first-generation’ Omicron sublineages ‘second-generation’ Omicron sublineages

Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
19 Dec 2023
Historique:
pubmed: 19 12 2023
medline: 19 12 2023
entrez: 19 12 2023
Statut: aheadofprint

Résumé

SARS-CoV-2 Omicron subvariants are still emerging and spreading worldwide. These variants contain a high number of polymorphisms in the spike (S) glycoprotein that could potentially impact their pathogenicity and transmission. We have previously shown that the S:655Y and P681H mutations enhance S protein cleavage and syncytia formation. Interestingly, these polymorphisms are present in Omicron S protein. Here, we characterized the cleavage efficiency and fusogenicity of the S protein of different Omicron sublineages. Our results showed that Omicron BA.1 subvariant is efficiently cleaved but it is poorly fusogenic compared to previous SARS-CoV-2 strains. To understand the basis of this phenotype, we generated chimeric S protein using combinations of the S1 and S2 domains from WA1, Delta and Omicron BA.1 variants. We found that the S2 domain of Omicron BA.1 hindered efficient cell-cell fusion. Interestingly, this domain only contains six unique polymorphisms never detected before in ancestral SARS-CoV-2 variants. WA1

Identifiants

pubmed: 38112266
doi: 10.1080/22221751.2023.2297553
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2297553

Auteurs

Alba Escalera (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

Manon Laporte (M)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Sam Turner (S)

Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK.

Umut Karakus (U)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Ana S Gonzalez-Reiche (AS)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

Adriana van de Guchte (A)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

Keith Farrugia (K)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

Zain Khalil (Z)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.

Harm van Bakel (H)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
Icahn Genomics Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Derek Smith (D)

Center for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge, UK.

Adolfo García-Sastre (A)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Department of Medicine, Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, USA.
Department of Pathology, Molecular and Cell-Based Medicine, Icahn School of Medicine at Mount Sinai, New York, USA.
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, USA.
Lead contact.

Teresa Aydillo (T)

Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai, New York, USA.

Classifications MeSH